The Acadia Healthcare Company Inc (ACHC) Downgraded to “Market Perform” at Leerink Swann

The Acadia Healthcare Company Inc (ACHC) Downgraded to “Market Perform” at Leerink Swann

Several other equities research analysts have also recently commented on the company. Jefferies Group LLC reaffirmed a “buy” rating on shares of Acadia Healthcare Company in a research note on Friday, May 5th. Zacks Investment Research raised Acadia Healthcare Company from a “sell” rating to a “hold” rating in a research note on Friday, April 28th. Cantor Fitzgerald reissued a “hold” rating and issued a $45.00 price objective on shares of Acadia Healthcare Company in a research note on Wednesday, April 26th. Deutsche Bank AG initiated coverage on Acadia Healthcare Company in a research note on Wednesday, April 5th. They issued a “buy” rating and a $53.00 price objective for the company. Finally, TheStreet raised Acadia Healthcare Company from a “d+” rating to a “c-” rating in a research note on Friday, March 3rd. Four equities research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $57.82.

Acadia Healthcare Company Inc (NASDAQ:ACHC) was downgraded by investment analysts at Leerink Swann from an “outperform” rating to a “market perform” rating in a research note issued on Monday, May 15th.

Acadia Healthcare Company (ACHC) opened at 43.69 on Monday. Acadia Healthcare Company has a 12 month low of $32.54 and a 12 month high of $63.67. The company has a market cap of $3.84 billion, a price-to-earnings ratio of 254.01 and a beta of 0.91. The company has a 50-day moving average of $43.41 and a 200-day moving average of $40.48.

In other Acadia Healthcare Company news, VP Randall P. Goldberg sold 914 shares of the business’s stock in a transaction on Wednesday, March 8th. The stock was sold at an average price of $43.55, for a total value of $39,804.70. Following the sale, the vice president now directly owns 7,376 shares in the company, valued at $321,224.80. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, VP Randall P. Goldberg sold 4,925 shares of the business’s stock in a transaction on Thursday, May 4th. The shares were sold at an average price of $45.18, for a total value of $222,511.50. Following the completion of the sale, the vice president now owns 10,607 shares in the company, valued at $479,224.26. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 92,322 shares of company stock worth $4,104,756. Corporate insiders own 17.20% of the company’s stock. Several hedge funds have recently added to or reduced their stakes in the stock. Price T Rowe Associates Inc. MD raised its stake in Acadia Healthcare Company by 11.2% in the third quarter. Price T Rowe Associates Inc. MD now owns 10,958,149 shares of the company’s stock worth $542,976,000 after buying an additional 1,103,621 shares during the last quarter. JPMorgan Chase & Co. raised its stake in Acadia Healthcare Company by 0.8% in the first quarter. JPMorgan Chase & Co. now owns 7,705,975 shares of the company’s stock worth $335,980,000 after buying an additional 59,735 shares during the last quarter. Vanguard Group Inc. raised its stake in Acadia Healthcare Company by 8.1% in the first quarter. Vanguard Group Inc. now owns 5,743,233 shares of the company’s stock worth $250,404,000 after buying an additional 431,550 shares during the last quarter. BlackRock Inc. raised its stake in Acadia Healthcare Company by 27,497.3% in the first quarter. BlackRock Inc. now owns 5,145,786 shares of the company’s stock worth $224,356,000 after buying an additional 5,127,140 shares during the last quarter. Finally, Aristotle Capital Management LLC bought a new stake in Acadia Healthcare Company during the first quarter worth about $140,071,000.

About Acadia Healthcare Company Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “NASDAQ:ACHC”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Receive News & Ratings for Acadia Healthcare Company Inc Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Acadia Healthcare Company Inc and related companies with our FREE daily email newsletter.

Related posts

Leave a Comment